ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TVTX Travere Therapeutics Inc

7.17
-0.07 (-0.97%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Travere Therapeutics Inc NASDAQ:TVTX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.07 -0.97% 7.17 6.95 19.00 7.24 7.02 7.10 815,273 05:00:05

Travere Therapeutics to Present at the Guggenheim 6th Annual Biotechnology Conference

01/02/2024 9:30pm

GlobeNewswire Inc.


Travere Therapeutics (NASDAQ:TVTX)
Historical Stock Chart


From Dec 2023 to Jun 2024

Click Here for more Travere Therapeutics Charts.

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will present at the Guggenheim 6th Annual Biotechnology Conference on Thursday, February 8, 2024, at 11:30 a.m. ET.

A live webcast will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations, and a replay will be available for up to 30 days following the event.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.

Contact:

Investors:888-969-7879                                        ir@travere.comMedia:888-969-7879                                        mediarelations@travere.com

 

 

1 Year Travere Therapeutics Chart

1 Year Travere Therapeutics Chart

1 Month Travere Therapeutics Chart

1 Month Travere Therapeutics Chart

Your Recent History

Delayed Upgrade Clock